A recent study presented at the 2026 European Respiratory Society Congress indicates that semaglutide, a medication primarily used for diabetes and weight loss, may significantly reduce asthma attacks and COPD flare-ups. The findings suggest a 40% reduction in asthma attacks and…
A recent NIH-funded study indicates that semaglutide, a key ingredient in GLP-1 drugs like Ozempic, may extend lifespan and improve various health markers in older mice. The resea…
Recent research indicates that semaglutide, a medication commonly used for type 2 diabetes and weight management, may also reduce asthma attacks by nearly 40% and COPD flare-ups b…
A recent analysis reveals that prescription rates for GLP-1 weight-loss medications, such as Wegovy and Mounjaro, are significantly lower in England's most deprived areas, despite…
A recent study indicates that semaglutide, a GLP-1 drug commonly used for weight loss, may extend lifespan and improve health markers in elderly mice, mimicking the effects of cal…
The article highlights the historical separation between the fields of eating disorders and obesity, emphasizing the need for a collaborative approach to improve patient assessmen…
This article explores how GLP-1 medications, such as semaglutide, may influence emotional states and motivation, potentially leading to a phenomenon described as 'Ozempic personal…
A recent study published in Nature Medicine investigates various interventions that could potentially slow down aging by analyzing epigenetic biomarkers. Researchers found that a…
Recent research indicates that GLP-1 weight-loss drugs, such as semaglutide, may not only aid in weight management but also extend lifespan in older female mice. The study found t…
As metabolic health gains prominence in wellness discussions, the roles of NAD+ and GLP-1 therapies are increasingly scrutinized. This article clarifies how GLP-1 medications like…
A study published in Nature suggests that GLP-1 obesity drugs, such as semaglutide, may extend lifespan and improve health in older female mice. The research indicates that treate…
Researchers at the University of California, Berkeley, have identified an oral compound named TOFA that significantly reduces body weight in obese mice by boosting energy expendit…
Yale researchers have revealed a new certification process for anti-aging treatments that mandates diet and prescription medications while deeming popular supplements ineffective,…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…